RI Dx Inc. is a medical diagnostic company based on an advanced nanotechnological platform developed by The National Aeronautics and Space Administration. We develop a handheld multiplexed point-of-care testing system (xPOCT) with performance characteristics comparable to the central laboratory.
ADVANTAGES OF MULTIPLEXED POINT-OF-CARE TESTING
1
Efficiency
The testing is performed at the bedside or in close proximity to the location of patient care. The testing is performed within the clinical management setting. Determination of need for testing is made at the bedside with the testing being implemented within a short time frame.
2
Speed of diagnosis and treatment
Rapid test results with the potential to expedite medical decision-making. In addition to the rapid implementation of treatment, the process is more efficient for the physician, as there is not a need to refamiliarize with the case after test results are returned from a central laboratory.
3
Expanded testing capabilities
Wide variety of sites both within and outside of the health care facility including ambulances. Possible non-traditional testing locations or circumstances include, but are not limited to, underserved populations, rural areas, and locations with limited infrastructure or personnel.
4
Specimen stability and ease of handling
Unprocessed samples, such as whole blood, that do not require processing. Reduced potential for sample deterioration, since most POCT is initiated and performed rapidly once the sample is obtained.
5
Lean process
Fewer steps are necessary to produce the result, including the elimination of processing, transport the specimen to the core laboratory, and communicating results back to the clinical staff.
6
Portable devices
- Diminished space requirements for operation and storage.
- Wide menu of analytes.
- Allows testing to be performed in a variety of locations.